Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare.
The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry.
Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.
Be Well: Benefits of Walking
A bedbug infestation is sweeping through the city of Paris and is being addressed by the French government.
Cheddar News checks in with your weather forecast for Monday, Oct. 2, 2023.
Tens of thousands of Kaiser Permanente workers could strike this week.
Scientists Katalin Karikó and Drew Weissman won the Nobel Prize in medicine for their research that helped pave the way for the mRNA vaccines.
An alternative mental health court program designed to fast-track people with untreated schizophrenia and other psychotic disorders into housing and medical care — potentially without their consent — kicked off in seven California counties, including San Francisco, on Monday.
U.S. health officials plan to endorse a common antibiotic as a morning-after pill that gay and bisexual men can use to try to avoid some increasingly common sexually transmitted diseases.
Canadian wildfires are again set to affect the northeastern part of the U.S.
A new study reveals that yelling and shouting at children can be as damaging as physical and sexual abuse.
Scientists Katalin Karikó and Drew Weissman won the Nobel Prize in medicine for their research that helped pave the way for the mRNA vaccines.
